Data gathered: June 22
AI Stock Analysis - Boston Scientific (BSX)
Analysis generated February 14, 2025. Powered by Chat GPT.
Boston Scientific Corporation is a globally recognized medical device company headquartered in Marlborough, Massachusetts. The company specializes in developing, manufacturing, and marketing a variety of medical solutions aimed primarily at addressing cardiovascular, digestive, pulmonary, and urological health issues. Boston Scientific has established itself as a leader in the healthcare sector, priding itself on innovation and a commitment to advancing patient care.
Stock Alerts - Boston Scientific (BSX)
![]() |
Boston Scientific | June 9 Gilbert Cisneros (member of U.S. congress) is selling shares |
![]() |
Boston Scientific | June 5 Insider Alert: Fitzgerald Joseph Michael is selling shares |
![]() |
Boston Scientific | June 4 Insider Alert: Mahoney Michael F is selling shares |
![]() |
Boston Scientific | June 1 Job postings are down by 24% in the last couple of days. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Boston Scientific
Alternative Data | Value | 3m Change | Trend | Benchmark | |
---|---|---|---|---|---|
Job Posts | 852 | Sign up | Sign up | Sign up | |
Sentiment | 92 | Sign up | Sign up | Sign up | |
Webpage traffic | 616,000 | Sign up | Sign up | Sign up | |
Employee Rating | 82 | Sign up | Sign up | Sign up | |
Google Trends | 81 | Sign up | Sign up | Sign up | |
Patents | 3,852 | Sign up | Sign up | Sign up | |
4chan Mentions | N/A | Sign up | Sign up | Sign up | |
Facebook Engagement | 273 | Sign up | Sign up | Sign up | |
Facebook Followers | 71,831 | Sign up | Sign up | Sign up | |
Reddit Mentions | N/A | Sign up | Sign up | Sign up | |
Stocktwits Mentions | 15 | Sign up | Sign up | Sign up | |
Stocktwits Subscribers | 6,313 | Sign up | Sign up | Sign up | |
Twitter Followers | 40,712 | Sign up | Sign up | Sign up | |
Twitter Mentions | 50 | Sign up | Sign up | Sign up | |
News Mentions | N/A | Sign up | Sign up | Sign up | |
Customer reviews | N/A | Sign up | Sign up | Sign up | |
ESG | N/A | Sign up | Sign up | Sign up | |
Lobbying Cost | $133,000 | Sign up | Sign up | Sign up | |
Business Outlook | 79 | Sign up | Sign up | Sign up | |
Linkedin Employees | 49,101 | Sign up | Sign up | Sign up | |
NPS | 24 | Sign up | Sign up | Sign up |
About Boston Scientific
Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Price | $101.30 |
Target Price | Sign up |
Volume | 9,590,000 |
Market Cap | $150B |
Year Range | $83.62 - $106.66 |
Dividend Yield | 0% |
PE Ratio | 73.99 |
Analyst Rating | 95% buy |
Industry | Medical Devices |
In the news
![]() |
Cornerstone Wealth Management LLC Trims Stock Holdings in Boston Scientific Corporation (NYSE:BSX)June 21 - ETF Daily News |
![]() |
Mission Wealth Management LP Makes New Investment in Boston Scientific Corporation (NYSE:BSX)June 20 - ETF Daily News |
![]() |
FY2025 Earnings Estimate for BSX Issued By Leerink PartnrsJune 19 - ETF Daily News |
![]() |
24-Acre Minnetonka Complex Put Up for Sale by Boston Scientific (BSX)June 19 - Yahoo |
![]() |
Exchange Traded Concepts LLC Sells 574 Shares of Boston Scientific Corporation (NYSE:BSX)June 19 - ETF Daily News |
![]() |
Boston Scientific (NYSE:BSX) Upgraded to “Strong-Buy” at Leerink PartnrsJune 18 - ETF Daily News |
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
---|---|---|---|---|---|---|
Q1 '25 | 4.66B | 1.45B | 3.21B | 674M | 1.21B | 0.750 |
Q4 '24 | 4.56B | 1.47B | 3.1B | 566M | 1.01B | 0.700 |
Q3 '24 | 4.21B | 1.31B | 2.9B | 468M | 1.05B | 0.630 |
Q2 '24 | 4.12B | 1.54B | 2.59B | 324M | 812M | 0.620 |
Q1 '24 | 3.86B | 1.21B | 2.65B | 492M | 984M | 0.560 |
Insider Transactions View All
Fitzgerald Joseph Michael filed to sell 178,342 shares at $102.9. June 4 '25 |
Mahoney Michael F filed to sell 1,566,803 shares at $104.1. June 3 '25 |
Mahoney Michael F filed to sell 1,476,882 shares at $103.4. June 3 '25 |
LUDWIG EDWARD J filed to sell 22,479 shares at $104.6. May 30 '25 |
Brown Vance R filed to sell 31,367 shares at $106.4. May 22 '25 |
Similar companies
Congress Trading View All
Politician | Filing Date | Type | Size |
---|---|---|---|
Gilbert Cisneros |
Jun 9, 25 | Sell | $1K - $15K |
Bruce Westerman |
May 13, 25 | Sell | $1K - $15K |
Gil Cisneros |
May 7, 25 | Sell | $1K - $15K |
Read more about Boston Scientific (BSX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Boston Scientific?
The Market Cap of Boston Scientific is $150B.
What is Boston Scientific's PE Ratio?
As of today, Boston Scientific's PE (Price to Earnings) ratio is 73.99.
What is the current stock price of Boston Scientific?
Currently, the price of one share of Boston Scientific stock is $101.30.
How can I analyze the BSX stock price chart for investment decisions?
The BSX stock price chart above provides a comprehensive visual representation of Boston Scientific's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Boston Scientific shares. Our platform offers an up-to-date BSX stock price chart, along with technical data analysis and alternative data insights.
Does BSX offer dividends to its shareholders?
As of our latest update, Boston Scientific (BSX) does not offer dividends to its shareholders. Investors interested in Boston Scientific should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Boston Scientific?
Some of the similar stocks of Boston Scientific are Edwards Lifesciences, Intuitive Surgical, Medtronic, Stryker, and Becton Dickinson and Co.
.